Hereditary Pancreatic Cancer.

Authors

Elana Levinson, Kimberly Hilfrank, Sheila D Rustgi, Fay Kastrinos

Published in

Gastroenterology clinics of North America. Volume 55. Issue 4. Pages 599-616. Epub Aug 25, 2026.

Abstract

Pancreatic cancer remains one of the deadliest malignancies, with most patients presenting at advanced stages and experiencing poor survival outcomes. Approximately 10% to 15% of cases are associated with inherited genetic susceptibility, highlighting the critical role of germline genetic testing and family history assessment. Multiple hereditary cancer syndromes, including those involving BRCA1, BRCA2, ATM, PALB2, CDKN2A, STK11, TP53, and select Lynch syndrome mismatch repair genes, confer increased risk of pancreatic cancer. Universal germline testing, cascade testing of at-risk relatives, and individualized risk assessment facilitate precision oncology and early detection. Screening for pancreatic cancer using select imaging modalities enables earlier-stage diagnosis and improves survival.

PMID:
42933936
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.